Session II:
“Clinical Research - Towards Personalized & Targeted Pancreatic Cancer Treatments”
Moderated by Elizabeth Jaffee, MD, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and Lustgarten Chief Medical Advisor, this session will feature three distinguished academics focusing on the latest advancements in identifying pancreatic cancer subtypes, predicting therapeutic response, and designing clinical trials for personalized treatments.
The panel Q&A discussion will ask us to think more critically and explore the complexities of developing these new approaches that could improve patient outcomes and pave the way for more effective pancreatic cancer therapies.
Session II: Speakers
HETEROGENEITY AND SUBTYPING
Jen Jen Yeh, MDUNC Medicine
PREDICTING THERAPEUTIC RESPONSE
Jennifer J. Knox, MSc, MD, FRCPCPrincess Margaret Cancer Centre
CLINICAL TRIALS
Vinod P. Balachandran, MDMemorial Sloan Kettering Cancer Center
